Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

BVF Partners with participation from the T1D Fund, Invus, Montanova, Eli Lilly and Company, Kura Oncology, members ...

82% of Organizations Had to Explain an Identity Decision, and One-Third Could Provide Only Limited Evidence

RESTON, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- 82% of organizations have been asked to document or explain an identity-related decision to a ...
Business Insider

iShares Latin America 40 ETF

Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...